• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】11703

【品名】D-Phenylalanine; (R)-Phenylalanine

【CA登记号】673-06-3

【 分 子 式 】C9H11NO2

【 分 子 量 】165.19188

【元素组成】C 65.44% H 6.71% N 8.48% O 19.37%

与该中间体有关的原料药合成路线共 4 条

合成路线1

该中间体在本合成路线中的序号:(VI)

The hydrogenation of 4-isopropylbenzoic acid (I) with H2 over PtO2 in acetic acid gives 4-isopropylcyclohexanecarboxylic acid as a mixture of cis- and trans-isomers (II). This mixture is esterified with methanol to the corresponding mixture of methyl esters (III), which is isomerized with NaH at 150 C without solvent, affording the trans-methyl ester (IV). Hydrolysis of (IV) with NaOH in methanol - water gives the free acid (V), which is finally condensed with D-phenylalanine (VI) by means of N-hydroxysuccinimide and dicyclohexylcarbodiimide in chloroform.

1 Toyoshima, S.; Seto, Y.; Shinkai, H.; Toi, K.; Kumashiro, I. (Ajinomoto Co., Inc.); Hypoglycemic agent. EP 0196222; US 4816484 .
2 Shinkai, H.; Dan, K.; Toi, K.; Kumashiro, I.; Seto, Y.; Toyoshima, S.; Nishikawa, M.; Fukuma, M.; Sato, Y.; N-(Cyclohexyl)carbonyl-D-phenylalanines and related compounds. A new class of oral hypoglycemic agents. 2. J Med Chem 1989, 32, 7, 1436.
3 Prous, J.; Graul, A.; Castaner, J.; AY-4166. Drugs Fut 1993, 18, 6, 503.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11698 4-Isopropylbenzoic acid 536-66-3 C10H12O2 详情 详情
(II) 11699 4-Isopropylcyclohexanecarboxylic acid C10H18O2 详情 详情
(III) 11700 methyl 4-isopropylcyclohexanecarboxylate C11H20O2 详情 详情
(IV) 11701 methyl 4-isopropylcyclohexanecarboxylate C11H20O2 详情 详情
(V) 11702 4-Isopropylcyclohexanecarboxylic acid C10H18O2 详情 详情
(VI) 11703 D-Phenylalanine; (R)-Phenylalanine 673-06-3 C9H11NO2 详情 详情

合成路线2

该中间体在本合成路线中的序号:

CP-72467-2 has been prepared by two synthetic routes which share a common intermediate. 1) In the initial route, diazotization of D-phenylalanine followed by esterification afforded the methyl ester of (R)-phenyllactic acid (I). Mitsunobu coupling with methyl 4-hydroxybenzoate using diisopropyl azodicarboxylate, selective reduction with sodium borohydride, and conversion to the bromide by in situ generation of triphenylphosphine dibromide produced intermediate (II). Friedel-Crafts alkylation of (II) using alpha-hydroxyhippuric acid/methanesulfonic acid, azalactone formation with acetic anhydride/triethylamine, followed by in situ spiroalkylation produced the N-benzoyl amino acid (III). Oxidative decarboxylation of (III) with 15% sodium hypochlorite led to the chromanone (V), presumably through hydrolysis of the intermediate N-benzoyl imine (IV). Catalytic hydrogenation over 10% Pd on carbon of the chromanone (V), reduction of the ester with Red-Al, and subsequent oxidation of the alcohol with manganese dioxide afforded the key aldehyde intermediate (VI). Condensation of aldehyde (VI) with 2,4-thiazolidinedione/pyridine, catalytic hydrogenation of the resultant olefin, and salt formation with sodium methoxide produced CP-72467-2. 2) An alternative synthesis of the key intermediate aldehyde (VI) utilizes an enzymatic resolution of the benzopyran ester (VII). Reduction of the 2(R)-ester with sodium borohydride followed by reaction with triflic anhydride generates the triflate (VIII). Copper-catalyzed reaction of the triflate (VIII) with phenyl magnesium bromide afforded the benzyl derivative (IX), which is readily formylated with phosphorous oxychloride/N-methyl formanilide to produce aldehyde (VI).

1 Clark, D.A.; Goldstein, S.W.; Volkmann, R.A.; et al.; Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents. J Med Chem 1991, 34, 1, 319.
2 Stevenson, R.W.; Urban, F.J.; Clark, D.A.; Englitazone Sodium. Drugs Fut 1992, 17, 3, 182.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
11703 D-Phenylalanine; (R)-Phenylalanine 673-06-3 C9H11NO2 详情 详情
((VII)-R) 13885 ethyl (2R)-3,4-dihydro-2H-chromene-2-carboxylate C12H14O3 详情 详情
(I) 13878 methyl (2R)-2-hydroxy-3-phenylpropanoate C10H12O3 详情 详情
(II) 13879 methyl 4-[[(1S)-1-benzyl-2-bromoethyl]oxy]benzoate C17H17BrO3 详情 详情
(III) 13880 (2S)-4-(Benzoylamino)-2-benzyl-6-(methoxycarbonyl)-3,4-dihydro-2H-chromene-4-carboxylic acid C26H23NO6 详情 详情
(IV) 13881 methyl (2S)-4-(acetylimino)-2-benzyl-2,3-dihydro-4H-chromene-6-carboxylate C20H19NO4 详情 详情
(V) 13882 methyl (2S)-2-benzyl-4-oxo-3,4-dihydro-2H-chromene-6-carboxylate C18H16O4 详情 详情
(VI) 13883 (2R)-2-Benzyl-3,4-dihydro-2H-chromene-6-carbaldehyde C17H16O2 详情 详情
(VII) 13884 ethyl 2-chromanecarboxylate C12H14O3 详情 详情
(VIII) 13886 (2R)-3,4-dihydro-2H-chromen-2-ylmethyl trifluoromethanesulfonate C11H11F3O4S 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

D-Phenylalanine (I) was protected as the methyl carbamate (II) by acylation with methyl chloroformate under Schotten-Baumann conditions. The N-methoxy amide (III) was then prepared by coupling of (II) with O-methyl hydroxylamine in the presence of EDC. Cyclization of (III) to the N-methoxy quinolinone (IV) was accomplished by treatment with bis(trifluoroacetoxy)iodobenzene in the presence of trifluoroacetic acid. Simultaneous reduction of the N-methoxy lactam and carbamate functions of (IV) by means of borane-methyl sulfide complex provided diamine (V). The aliphatic amino group of (V) was then selectively protected as the benzyl carbamate (VI) by using N-(benzyloxycarbonyloxy)succinimide at -40 C. Reaction of (VI) with phosgene, followed by treatment of the intermediate carbamoyl chloride with O-methyl hydroxylamine gave rise to the N-methoxy urea derivative (VII). This was cyclized with bis(trifluoroacetoxy)iodobenzene to the imidazoquinolinone (VIII). The N-methoxy and N-benzyloxycarbonyl groups of (VIII) were then removed by hydrogenolysis in the presence of Pearlman's catalyst, and the title compound was finally converted to the corresponding maleate salt.

1 Romero, A.G.; et al.; Synthesis of the selective D2 receptor agonist PNU-95666E from D-phenylalanine using a sequential oxidative cyclization strategy. J Org Chem 1997, 62, 19, 6582.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11703 D-Phenylalanine; (R)-Phenylalanine 673-06-3 C9H11NO2 详情 详情
(II) 55860 (2R)-2-[(methoxycarbonyl)amino]-3-phenylpropanoic acid C11H13NO4 详情 详情
(III) 55861 methyl (1R)-1-benzyl-2-(methoxyamino)-2-oxoethylcarbamate C12H16N2O4 详情 详情
(IV) 55862 methyl (3R)-1-methoxy-2-oxo-1,2,3,4-tetrahydro-3-quinolinylcarbamate C12H14N2O4 详情 详情
(V) 55863 N-methyl-N-[(3R)-1,2,3,4-tetrahydro-3-quinolinyl]amine; (3R)-N-methyl-1,2,3,4-tetrahydro-3-quinolinamine C10H14N2 详情 详情
(VI) 55864 benzyl methyl[(3R)-1,2,3,4-tetrahydro-3-quinolinyl]carbamate C18H20N2O2 详情 详情
(VII) 55865 benzyl (3R)-1-[(methoxyamino)carbonyl]-1,2,3,4-tetrahydro-3-quinolinyl(methyl)carbamate C20H23N3O4 详情 详情
(VIII) 55866 benzyl (5R)-1-methoxy-2-oxo-1,2,5,6-tetrahydro-4H-imidazo[4,5,1-ij]quinolin-5-yl(methyl)carbamate C20H21N3O4 详情 详情

合成路线4

该中间体在本合成路线中的序号:(III)

 

1 Chen SN, Feng QJ, Yu YM, et aL 2007. Preparation of H type nateglinide crystal.发明专利申请公开说明书.CN 1887858 (Hangzhou Pollen Co, Ltd, Peop Rep China)
2 Wang D, Liang YH, Gang P,et aL 2002.A new synthesis method of nateglinide as antidiabetic drug. 中国药物化学杂志,12 (2): 94~96
3 Yahalomi R 2004. Process for preparing nateglirude and intermediates thereof. W0 2004005240[本专利为Teva Pharmaceutical Industries Ltd (IL)-所有]
4 Zhu XY, Peng K, Wang XQ, et aL 2001. Synthesis of nateglinide.合成化学,9(6): 537~540
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 11702 4-Isopropylcyclohexanecarboxylic acid C10H18O2 详情 详情
(II) 66534 4-isopropylcyclohexanecarbonyl chloride   C10H17ClO 详情 详情
(III) 11703 D-Phenylalanine; (R)-Phenylalanine 673-06-3 C9H11NO2 详情 详情
Extended Information